{
    "2021-10-31": [
        [
            {
                "time": "",
                "original_text": "国金证券给予华兰生物买入评级：业绩增长靓丽，血制品疫苗双轮驱动",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "买入评级",
                        "业绩增长",
                        "血制品",
                        "疫苗",
                        "双轮驱动"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国金证券：给予华兰生物买入评级",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "买入评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "平安证券给予华兰生物推荐评级：流感疫苗如期放量，带动业绩增长",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "推荐评级",
                        "流感疫苗",
                        "放量",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "平安证券：给予华兰生物增持评级",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "增持评级"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}